| DagangNews - Berita Bisnes Anda
Terkini - 09 Jun 2026 06:21 PM

Kee Ming peroleh subkontrak RM21.36 juta projek pembangunan pusat data di Puncak Alam

KUALA LUMPUR 9 Jun — Kee Ming Group Berhad memperoleh subkontrak yang bernilai RM21.36 juta bagi melaksanakan perkhidmatan kejuruteraan elektrik untuk sebuah projek pusat data (DC).

 

Terkini - 09 Jun 2026 06:33 PM
KWSP, PNB dan KWAP salur modal sokong transformasi syarikat tersenarai menerusi inisiatif 'My Value Up'

KUALA LUMPUR 9 Jun – Syarikat pelaburan berkaitan kerajaan iaitu Kumpulan Wang Simpanan Pekerja (KWSP), Permodalan Nasional Berhad (PNB) dan Kumpulan Wang Persaraan (KWAP) akan memperuntukkan sebahagian modal bagi menyokong transformasi syarikat tersenarai yang berpotensi.

English - 09 Jun 2026 05:00 PM
Rhenus Group Sustainability Report 2025 highlights shift from groundwork to global performance
  • Centralised sustainability framework, SBTi commitment and EcoVadis Platinum status mark 2025 as a milestone for Rhenus Group
  • Operational progress includes safety improvements, high recycling rates and low-emission transport innovations such
English - 09 Jun 2026 05:10 PM
DHL expands Asia Pacific data center logistics capabilities to support growing regional demand
  • DHL Supply Chain adds more than 160,000 sqm of dedicated warehousing capacity in Asia Pacific to meet rising demand for data centers
  • Enhanced capabilities include upskilling workforce in advanced white glove handling and investing in specialized technical services <
English - 09 Jun 2026 05:25 PM
Dusit International strengthens India expansion with signing of Dusit Princess Rishikesh in Uttarakhand

The upscale mixed-use development will feature luxury duplex villas, hotel rooms and lifestyle-led amenities in one of India’s leading wellness and spiritual destinations

Terkini - 09 Jun 2026 05:20 PM
Duopharma raih kontrak tiga tahun bekal insulin kepada KKM bernilai RM155 juta

KUALA LUMPUR 9 Jun – Duopharma Biotech Berhad menerusi anak syarikat milik penuhnya, Duopharma (M) Sdn Bhd (DMSB) memperoleh kontrak bekalan insulin manusia rekombinan bernilai kira-kira RM155.28 juta daripada Kementerian Kesihatan Malaysia (KKM).